Cardiovascular system Increased resting heart rate Venous thrombosis Early increased cardiac stroke Respiratory system Reduced tidal volume Potential permanent restrictive pulmonary disease due to fixed contractures of the costovertebral joints…
Organization Definition Diagnostic criteria to identify muscle mass loss Diagnostic criteria to characterize functional status Sarcopenia Working Group of the European Union Geriatric Medicine Society “Sarcopenia is a syndrome characterized…
© Springer International Publishing AG 2018Stefano Masiero and Ugo Carraro (eds.)Rehabilitation Medicine for Elderly PatientsPractical Issues in Geriatricshttps://doi.org/10.1007/978-3-319-57406-6_7 7. Motivation and Rehabilitation in Older Patients Carine Federspiel1 and Jean-Paul Steinmetz1 (1) Centre for Memory and Mobility –…
Atorvastatin 40 mg Daily Escitalopram 20 mg Mane Frusemide 40 mg BD Metoprolol 50 mg BD Paracetamol 1 G TDS Temazepam 10 mg Nocte Warfarin 1 mg Nocte OxyContin 5…
Fig. 16.1 Pulse wave form from healthy vasculature. P percussion wave, D dicrotic wave. The arrow indicates the dicrotic notch. The reflected wave or dicrotic wave is small and is…
Algorithm for Falls Assessment and Management 8.3 Risk Management As with many other strategies used in dealing with older patients, falls prevention needs a multidisciplinary approach [12, 13]. A Cochrane…
Essential features Variable features Acute onset Perceptual disturbance Fluctuating course Hyper/hypoactive Inattention Altered sleep/wake pattern Disorganised thoughts/speech Emotional disturbance Fluctuating consciousness Confusion Potential examination signs Autonomic dysfunction Dysarthria Tachycardia Dysnomia…
Fig. 1.1 Percentage of the population aged 60 years or over, 2015–2050. Source: UN Population Division 2015. http://esa.un.org/unpd/popdev/Profilesofageing2015/index.html Table 1.1 shows the change in median age for the world and…
CHAD2-VASC2 risk criteria Points Congestive heart failure/ LV dysfunction 1 Hypertension 1 Age >75 years 2 Diabetes mellitus 1 Prior stroke, TIA, thromboembolism 2 Peripheral vascular disease or coronary artery…
No of trials/patients Stroke OR (95% CI) Death OR (95% CI) MI OR (95% CI) Stroke/death OR (95% CI) 16/7572 Favours CEA 1.81 (1.40–2.34) No difference 1.59 (0.94–2.70) Favours CAS…
